Terminated NA INTERVENTIONAL 2-arm NCT05374941

StimAire Sleep Study

An Interventional Open Feasibility Sleep Study to Determine Effectiveness of StimAire's Injectable and Wearable Neurostimulator in Participants With Obstructive Sleep Apnea

Sponsor: StimAire Australia Pty Ltd

Conditions Obstructive Sleep Apnea

Interventions Injectable and wearable neurostimulator for the hypoglossal nerve

Updated 5 times since 2022 Last updated: Apr 16, 2024 Started: Aug 17, 2022 Primary completion: Apr 12, 2023 Completion: Apr 12, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Technical issues related to the intervention

Other Obstructive Sleep Apnea trials with similar outcome

Browse all Obstructive Sleep Apnea trials

This NA trial investigates Obstructive Sleep Apnea and is currently terminated or withdrawn. StimAire Australia Pty Ltd leads this study, which shows 5 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
May 2024 — Jul 2024 [monthly]

Terminated NA

Status: Recruiting → Terminated
Nov 2022 — May 2024 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Jun 2022 — Nov 2022 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

StimAire Australia Pty Ltd

Data source: StimAire Australia Pty Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Sydney, Australia